Literature DB >> 19737063

Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle.

Daniel U Thomson1, Guy H Loneragan, Ashley B Thornton, Kelly F Lechtenberg, Daryl A Emery, Doug T Burkhardt, Triuvoor G Nagaraja.   

Abstract

OBJECTIVE: To quantify the efficacy of a siderophore receptor and porin (SRP) proteins-based vaccine on the burden of Escherichia coli O157:H7 in feedlot cattle.
METHODS: Two research trials were conducted in field conditions. In each trial, cattle (n = 1252 in trial #1; n = 1284 in trial #2) were systematically divided into 20 pens and were administered either the E. coli O157 SRP vaccine or a placebo (trial #1: days 0 and 21; trial #2: days 0, 21, and 42). Rectal fecal samples were collected on day 0, and pen floor samples were collected on days 21, 35, 70, and 85 for trial #1 and on days 42 and 98 for trial #2. On day 85 of trial #1, rectoanal mucosal swab samples and hide swab samples were collected. Cattle were weighed on days 0, 21, and 85 (trial #1) or 1 week before harvest (trial #2).
RESULTS: In trial #1, prevalence of E. coli in the feces was lower in vaccinates compared to control animals (p = 0.04). On day 85, the likelihood of an animal being positive at any site was less among vaccinates than controls (p = 0.02). In trail #2, vaccination with SRP was associated with reduced shedding by 85.2% on day 98 (p < 0.01) but not on days 0 or 42. Vaccination with SRP was associated with a 98.2% reduction in concentration of E. coli O157 in fecal samples (2.54 vs. 0.80 log MPN/g of feces; p < 0.01). Cattle performance was not affected by SRP administration.
CONCLUSIONS: The E. coli O157:H7 SRP-based vaccine might serve as a preharvest intervention to reduce the burden of E. coli O157:H7 on cattle presented for harvest.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737063     DOI: 10.1089/fpd.2009.0290

Source DB:  PubMed          Journal:  Foodborne Pathog Dis        ISSN: 1535-3141            Impact factor:   3.171


  18 in total

1.  The Escherichia coli O157:H7 cattle immunoproteome includes outer membrane protein A (OmpA), a modulator of adherence to bovine rectoanal junction squamous epithelial (RSE) cells.

Authors:  Indira T Kudva; Bryan Krastins; Alfredo G Torres; Robert W Griffin; Haiqing Sheng; David A Sarracino; Carolyn J Hovde; Stephen B Calderwood; Manohar John
Journal:  Proteomics       Date:  2015-03-09       Impact factor: 3.984

2.  Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization.

Authors:  Alexander Corbishley; Nur Indah Ahmad; Kirsty Hughes; Michael R Hutchings; Sean P McAteer; Timothy K Connelley; Helen Brown; David L Gally; Tom N McNeilly
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 3.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Vaccination with type III secreted proteins leads to decreased shedding in calves after experimental infection with Escherichia coli O157.

Authors:  Kevin J Allen; Dragan Rogan; B Brett Finlay; Andrew A Potter; David J Asper
Journal:  Can J Vet Res       Date:  2011-04       Impact factor: 1.310

5.  Insights into mucosal innate responses to Escherichia coli O157 : H7 colonization of cattle by mathematical modelling of excretion dynamics.

Authors:  Michael J Tildesley; David L Gally; Tom N McNeilly; J Chris Low; Arvind Mahajan; Nicholas J Savill
Journal:  J R Soc Interface       Date:  2011-08-17       Impact factor: 4.118

6.  Predicting the public health benefit of vaccinating cattle against Escherichia coli O157.

Authors:  Louise Matthews; Richard Reeve; David L Gally; J Chris Low; Mark E J Woolhouse; Sean P McAteer; Mary E Locking; Margo E Chase-Topping; Daniel T Haydon; Lesley J Allison; Mary F Hanson; George J Gunn; Stuart W J Reid
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

7.  An outcomes model to evaluate risks and benefits of Escherichia coli vaccination in beef cattle.

Authors:  H Scott Hurd; Sasidhar Malladi
Journal:  Foodborne Pathog Dis       Date:  2012-09-18       Impact factor: 3.171

8.  Proteins other than the locus of enterocyte effacement-encoded proteins contribute to Escherichia coli O157:H7 adherence to bovine rectoanal junction stratified squamous epithelial cells.

Authors:  Indira T Kudva; Robert W Griffin; Bryan Krastins; David A Sarracino; Stephen B Calderwood; Manohar John
Journal:  BMC Microbiol       Date:  2012-06-12       Impact factor: 3.605

9.  Passive immunization by recombinant ferric enterobactin protein (FepA) from Escherichia coli O157.

Authors:  Seyed Mehdi Larrie-Bagha; Iraj Rasooli; Seyed Latif Mousavi-Gargari; Zohreh Rasooli; Shahram Nazarian
Journal:  Iran J Microbiol       Date:  2013-06

10.  Native Human Antibody to Shr Promotes Mice Survival After Intraperitoneal Challenge With Invasive Group A Streptococcus.

Authors:  Nilanjana Chatterjee; Ya-Shu Huang; Kristin V Lyles; Julie E Morgan; Lawrence M Kauvar; Susanna F Greer; Zehava Eichenbaum
Journal:  J Infect Dis       Date:  2021-04-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.